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Objectives: To evaluate the results of total arterial revascularization with composite
grafts compared with the results of conventional coronary surgery, we enrolled 200
consecutive patient undergoing myocardial revascularization.
Methods: Patients were randomly assigned to 2 groups of 100 patients each: group
1 underwent total arterial revascularization, and group 2 received left internal
thoracic artery on left anterior descending artery grafts plus additional saphenous
vein grafts. The groups were comparable in terms of continuous and discrete
variables and preoperative risk factors.
Results: There were no differences between group 1 and group 2 in terms of the
number of grafted vessels (mean, 2.8 vs 2.9, respectively), crossclamping time
(mean, 38  7 vs 40  6 min, respectively), intensive care unit stay (mean, 25 
8 vs 24  7 hours, respectively), and hospital mortality (1% in both groups) nor
were there any differences in postoperative complications. At the mean follow-up of
12  4 months, patients receiving total arterial revascularization (group 1) showed
a better outcome in terms of angina recurrence (group 1 vs group 2: 2 vs 13 patients,
P  .007), need of percutaneous transluminal coronary angioplasty reintervention
(group 1 vs group 2: 0 vs 8 patients, P .0012), and actuarial freedom from cardiac
events (group 1 vs group 2: 96% vs 67%, P  .006). Angiography carried out in
72% in group 1 and in 68% in group 2 demonstrated a patency rate of 99% of
saphenous vein grafts in group 1 and 89% of saphenous grafts in group 2.
Conclusions: Total myocardial revascularization with composite arterial grafts
provided superior clinical results and improved patient outcome, even in the short
term to midterm. Arterial conduit–related benefits were clearly evident with respect
to recurrence of angina and a higher graft patency rate.
It has been recognized worldwide that the use of the left internal thoracicartery (LITA) to bypass the left anterior descending coronary artery (LAD)is the gold standard in coronary surgery because it provides a superior graftpatency rate and incremental long-term benefits.1-3More recently, the use of multiple arterial conduits has been advocated toextend those benefits to other coronary vessels, but contradictory clinical
reports,4-6 anatomic limitations of pedicled internal thoracic arteries (ITAs), and
doubtfulness about the functional properties of the radial and other arterial conduits
made many surgeons reluctant to face the issue of total arterial revascularization.
However, in the last few years, several studies have demonstrated that the use of
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multiple arterial grafts clearly improves the long-term out-
come of patients undergoing coronary surgery.7-9
To overcome the anatomic limitations of ITAs and to
expand the possibilities for full revascularization, the use of
composite arterial grafts has been reported in an increasing
number of studies,10-12 but few of them were prospective,
and none were randomized.
We designed our study to evaluate the safety and use-
fulness of composite grafts to achieve total arterial revas-
cularization and to compare results of total arterial revas-
cularization with those provided by means of conventional
coronary artery bypass graft (CABG) surgery. Outcome and
variables, such as postoperative course, complications,
death, recurrence of angina, graft occlusion, late cardiac-
related events, and reinterventions, were evaluated.
Methods
Patient Population and Criteria Selection
Between 1999 and 2001, we enrolled 200 patients undergoing
isolated on-pump CABG; patients less than 50 years of age, with
single-vessel disease, undergoing emergency operations, with left
ventricular ejection fractions of less than 25%, and with a Euro-
SCORE of greater than 7 were not included in the study.
The study protocol was approved by the institutional review
board, which excluded patients younger than 50 years of age from
this study because of ethical concerns about the use of saphenous
vein grafts (SVGs) in this group of patients. All patients included
in the study provided written informed consent relative to the type
of operation.
Patients were randomly assigned to group 1 (n 100) or group
2 (n  100): patients in group 1 underwent total arterial revascu-
larization with composite grafts, whereas patients in group 2
underwent myocardial revascularization by means of LITA on
LAD grafts plus additional SVGs.
The 2 groups were similar with respect to age (group 1 vs group
2: 67.06 9 vs 68.03 8 years, P .421), sex (group 1 vs group
2 [male/female]: 73/27 vs 75/25, P  .872), and preoperative
variables (Table 1). Composite arterial grafts in group 1 consisted
of in situ LITA on LAD grafts plus right internal thoracic artery
(RITA), radial artery (RA), or both, in Y/T grafts (Figure 1). The
use of RITA was avoided in patients with insulin-dependent dia-
betes mellitus with clinical evidence of microangiopathies, chronic
obstructive pulmonary disease with long-standing steroid treat-
ment, and obesity (body mass index 30). The RA was harvested
from the nondominant arm only in patients with negative Allen test
results, palpable ulnar pulses, and near to normal oximetric pleth-
ysmography curves from the thumb during RA occlusion.
Operative Technique
Both ITAs were harvested as pedicled conduits, titanium clips
were applied on side branches, electrocautery was avoided, and
distal ITA bifurcations were systematically preserved.
The RA was harvested together with its satellite veins and
connective tissue to minimize arterial wall damage and to prevent
spasm. After heparinization, the ITAs and RA were divided dis-
tally, and an intraluminal injection of papaverine hydrochloride
(200 mg of papaverine diluted in 100 mL of normal saline) was
administered. When used as a free graft, the RA was divided
proximally only before the related coronary anastomosis to avoid
spasm caused by unnecessary storage.
Composite arterial Y/T grafts were performed before cardio-
pulmonary bypass (CPB), and end-to-side anastomosis was carried
out on the fascial side of the LITA with an 8-0 polypropylene
running suture.
Standard CPB was instituted (mean flow, 2.5 L  min1 
m2) with moderate hypothermia (33°C), and antegrade-retro-
grade oxygenated cold blood cardioplegia was used. The threshold
degree of stenosis of coronary vessels was 70% for the use of the
RA and 60% for ITAs.
Distal anastomoses on target coronary vessels were performed
with 8-0 polypropylene running sutures for the arterial grafts and
7-0 sutures for SVGs; side-to-side anastomoses were done with a
diamond-shaped configuration, and RA distal anastomoses were
performed systematically as the last anastomosis.
Proximal anastomoses for SVGs were performed in standard
fashion, and aortic anastomoses of the RA were performed with
the interposition of a saphenous vein patch. Composite grafts were
used in 3 different configurations (Figure 1) according to patients’
characteristics, coronary anatomy, and target stenosis.
Type 1 configuration was used in cases of dominant (not
occluded) right coronary artery (RCA) grafts because in those
cases a composite graft totally dependent from the proximal LITA
inflow might not be adequate to warrant blood supply for the entire
coronary circulation.
Type 2 configuration was used in the case of nondominant or
occluded RCAs in the presence of borderline stenosis of obtuse
marginal branches or low run-off of the target coronary vessels.
This configuration is based on sequential anastomosis that might
maintain adequate flow through the RA or RITA, avoiding the
TABLE 1. Comparison of preoperative clinical variables
Variables
Group 1
(n  100)
Group 2
(n  100)
P
value
Age (y)
Mean 67.06  9 68.03  8 .421
Range 52-85 50-84
Sex (female) 27 25 .872
Hypertension 60 62 .885
COPD 19 22 .726
Diabetes 41 40 1
Hypercholesterolemia 40 38 .885
Obesity 6 8 .782
PVD 31 28 .756
Previous CVA 5 8 .566
Redo surgery 2 3 1
Renal dysfunction 3 5 .718
Unstable angina 27 32 .535
Ejection fraction
30%-50% 24 22 .867
30% 5 6 1
MI 90 d 41 37 .664
Double-vessel disease 26 29 .751
Euroscore 4  1.9 4.2  1.8 .446
COPD, Chronic obstructive pulmonary disease; PVD, peripheral vascular
disease; CVA, cerebrovascular accident; MI, myocardial infarction.
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threadlike phenomena or occlusion, even in the absence of critical
stenosis or in the case of poor run-off of the coronary vessel. We
considered type 2 configuration as the arrangement of first choice
for the use of composite arterial grafts because it avoids RITA
harvesting and aortic manipulation.
Type 3 configuration was considered as a rescue procedure
when type 1 or 2 configuration failed.
The switch from type 1 to type 3 configuration was usually
done in the presence of atheromatic lesions of the ascending aorta
and when the posterior descending coronary artery had to be
bypassed distally.
The switch from type 2 to type 3 configuration might be due to
unfavorable anatomy of the posterolateral coronary vessels (con-
vergence of the posterior descending coronary and obtuse marginal
branches). However, when problems occur during side-to-side
anastomosis on marginal branches, type 3 configuration might
represent a key rescue procedure: the RA is divided at the level of
the side-to-side anastomosis and can be turned easily into an
end-to-side standard anastomosis. The remaining segment of the
RA might be successfully used in most cases to reach the RCA
branches.
In patients receiving RA grafts, oral diltiazem was given the
day before the operation (60 mg every 8 hours). Intravenous
diltiazem infusion (mean dose, 0.5-1.5 g  kg1  min1) was
administered throughout the operation and during the first 48 hours
after the operation. Thereafter, diltiazem oral therapy (120 mg/d)
was continued for at least 6 months.
Patient Follow-up
Follow-up data were collected during clinical visits at 1.5, 6, and
12 months after the operation and thereafter by telephone inter-
view. Additional information was obtained from home physicians,
patients’ cardiologists, or both. Patients were assessed for survival
and survival free from any cardiac-related event, such as death,
myocardial infarction, recurrence of angina, percutaneous translu-
minal coronary angioplasty (PTCA), and surgical reintervention.
Clinical symptoms of angina recurrence were confirmed by means
of exercise testing and myocardial perfusion imaging (thallium-
201/technetium-99m).
Data Analysis
Values of continuous variables are expressed as means  SD.
Preoperative and perioperative continuous variables were com-
pared with the unpaired t test and the Wilcoxon rank-sum test; the
2 test was used for discrete variables. Actuarial event-free sur-
vival curves were estimated by using the Kaplan-Meier method
(SAS/STAT Statistical Package, PROC LIFETEST. User’s Guide,
Figure 1. Composite arterial graft configuration technique. A, Type 1: the RITA is anastomosed to the in situ LITA
as a Y graft; as a free graft, the RA is anastomosed to the RCA. B, Type 2: the RA is anastomosed to the LITA as
a Y graft. C, Type 3: the 2 segments of the RA are anastomosed to the LITA in a double Y graft fashion. PD, Posterior
descending coronary; DIAG, diagonal.
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Version 8; SAS Institute, Cary, NC). Multivariate analysis was
carried out by means of 2 different risk factor models. The Cox
regression model was used to analyze the effects of all the poten-
tially related variables, taking into account the time of occurrence
of the dependent variable (angina recurrence, PTCA, and late
death). Multivariate logistic regression analysis was carried out by
using the presence, absence, or both, of graft occlusion as a
dependent variable. For the Cox proportional hazard model, results
are presented in terms of hazard ratios (HRs), HR 95% confidence
intervals (CIs), and levels of statistical significance in terms of P
value. Multivariate logistic regression analysis results are ex-
pressed in terms of P values, odds ratios, and 95% CIs.
Results
Preoperative Data
Comparison of preoperative data and risk factors by means
of univariate analysis showed no differences between the
groups that were homogenous for continuous and discrete
variables (Table 1). Distribution of patients’ characteristics
was similar to that reported from other authors,12-14 except
for diabetes, the prevalence of which was particularly high
in both groups (group 1 vs group 2: 40% vs 41%).
Perioperative Data
There were no differences in the mean number of anasto-
moses nor were there any differences in terms of target
vessels between the 2 groups (Table 2). Aortic crossclamp-
ing time was similar, whereas CPB duration was signifi-
cantly higher in group 2 as a consequence of the proximal
SVG anastomoses (Table 2).
The conduit-type geometry of composite arterial grafts
are described in Figure 1: type 1 geometry was performed in
38 patients, and type 2 and type 3 geometry were performed
in 54 and 8 patients, respectively.
There was one (1%) hospital death in each group because
of sudden intractable ventricular fibrillation (without any
evidence of prearrhythmic hemodynamic abnormalities,
electrocardiographic abnormalities, or arterial graft spasm)
in group 1 and to prolonged mechanical ventilation leading
to sepsis in group 2. No significant differences were ob-
served between the groups in terms of intensive care unit
and postoperative stay; mechanical ventilatory support was
longer in group 2 (Table 3).
Univariate analysis showed no differences between the
groups with respect to postoperative complications (Table
3). Even patients undergoing double-ITA harvesting (n 
40) did not show any differences in terms of postoperative
complications when compared with group 2 (blood transfu-
sion: double-ITA group vs group 2, 37.5% vs 37%, P 
.883; prolonged mechanical ventilation: double-ITA group
vs group 2, 2.5% vs 3%, P  1; sternal dehiscence: double-
ITA group vs group 2, 2.5% vs 1%, P  .477).
Late Outcome and Survival
At the mean follow-up of 12  4 months, recurrence of
angina was significantly lower in group 1 (group 1 vs group
2: 2 vs 13 patients, P  .007).
Patients in group 1 showed a better outcome also in
terms of all other cardiac-related events when compared
with patients in group 2. The incidence of PTCA reinter-
ventions was significantly lower in group 1 (group 1 vs
group 2: 0 vs 8 patients, P  .012). Late occurrence of
myocardial infarction and cardiac-related death were also
lower in group 1, but differences between the groups did not
reach a significant statistical value (myocardial infarction:
group 1 vs group 2, 0 vs 2 patients, P  .477; late death:
group 1 vs group 2, 1 vs 3 patients, P  .641).
Angiography was carried out in all symptomatic patients
and at random in 72 patients of group 1 and in 68 patients
of group 2: graft patency was 99% of SVGs in group 1 and
TABLE 2. Comparison of intraoperative variables between
the 2 groups
Variables
Group 1
(n  100)
Group 2
(n  100)
P
value
No. of grafted vessels (mean) 2.8  0.8 2.9  0.6 .319
Vessels-conduits
LAD-LITA 100 100 .826
Diag-LITA/RITA/RA/SVG 19 13 .311
Cx-RITA/RA/SVG 87 89 .992
RCA-RITA/RA/SVG 74 88 .345
Crossclamping time (mean) 38  7.4 40  6.5 .336
Total CPB time (mean) 56  9 81  7 .001
Diag, Diagonal; Cx, circumflex.
TABLE 3. Comparison of postoperative variables and com-
plications
Variables
Group 1
(n  100)
Group 2
(n  100)
P
value
ICU stay (h) 25 8 24 7 .348
Mechanical ventilatory
support (h)
9 6.5 11 7.4 .044
Postoperative stay (d) 4.8 1.9 5 2 .469
Hospital mortality 1 1 .477
Atrial fibrillation 23 22 1
Blood transfusion 35 37 .883
Pneumothorax 3 2 1
Reoperation for bleeding 1 2 1
Acute renal failure 3 3 .678
CVA 0 1 1
IABP support 1 2 1
MI 1 2 1
Prolonged mechanical
ventilation
2 3 1
Intractable arrhythmia 1 0 1
Sternal dehiscence 1 1 .477
Intestinal ischemia 0 1 1
ICU, Intensive care unit; CVA, cerebrovascular accident; IABP, intra-aortic
balloon pump; MI, myocardial infarction.
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89% of SVGs in group 2 (15 SVGs occluded). Patency of
LITA (in group 1 and group 2) and RITA was 100%, with
no graft or Y anastomoses occluded. The RITA became
threadlike in 3 (7.5%) patients: in all of them, anastomosis
was carried out on obtuse marginal branches with a border-
line stenosis (approximately 70%). None of those patients
had symptoms.
There was only one arterial conduit occluded in group 1
(RA grafted on obtuse marginal branch), whereas among
137 SVGs in group 2, 15 conduits were occluded, with an
overall SVG patency rate of 89%. The patency of SVGs
used to bypass the circumflex system and the RCA was
91.6% (76/83 SVGs) and 85.2% (46/54 SVGs), respec-
tively.
Actuarial survival at 20 months was similar in the 2
groups (Figure 2); however, patients in group 1 had a
significantly better actuarial survival free from any cardiac
event (Figure 3). The presence of diabetes had a tremendous
effect on the outcome, with a significant reduction of actu-
arial survival free from late events (Figure 4).
We attempted to use the Cox proportional hazard model
to analyze the effects of the different potentially related
variables (presence of SVGs, diabetes, age 70 years, hy-
pertension, obesity, female sex, and EuroSCORE), taking
into account the time of occurrence of the dependent vari-
ables (angina, need of PTCA, and late death). Diabetes and
the presence of SVGs (group 2) were identified as incre-
mental risk factors for recurrence of angina (diabetes: P 
.0018, HR  25.92, 95% CI  3.35-200.35; SVGs: P 
.0088, HR  7.95, 95% CI  1.68-37.54), but the small
number of events made the hazard model unreliable, as
indicated by the extremely wide CIs. In addition, diabetes
was also an incremental risk factor for PTCA reintervention
(P  .04). The cumulative hazard of angina recurrence
showed a significantly higher risk (7.95 times) in group 2
(Figure 5).
Multivariate logistic regression analysis with the pres-
ence or absence of graft occlusion as a dependent variable
and the variables listed in Table 1 as independent variables
identified diabetes (P  .0006, odds ratio  42.34, 95%
CI  5.11-350.86) and SVGs (P  .0019, odds ratio 
30.04, 95% CI  3.52-255.81) as predictors for graft oc-
clusion, but because of the small number of events, the wide
CIs made the multivariate regression analysis unreliable.
Discussion
The ITA is recognized worldwide as the graft of choice for
myocardial revascularization because of its favorable prop-
erties, and the use of the LITA to bypass the LAD has been
able to steadily improve the results of CABG surgery across
time.1-3
Consequently, the use of bilateral ITAs has been advo-
cated to extend benefits to the circumflex artery and RCAs,
but contradictory clinical reports,4-6 concerns about sternal
Figure 2. Comparison of overall survival in patients receiving total arterial revascularization (full arterial) versus
conventional CABG surgery (conventional).
Surgery for Acquired Cardiovascular Disease Muneretto et al
830 The Journal of Thoracic and Cardiovascular Surgery ● April 2003
A
CD
devascularization, and the anatomic limitation of the RITA
made many surgeons skeptical about the advantages of
double ITAs.
In an attempt to overcome technical problems related to
the use of the RITA and to reduce the rate of bilateral ITA
harvesting, alternative arterial conduits have been stud-
ied.15-17
Among them, the RA was the conduit most extensively
studied and used.15,18-22 Today, the RA is more frequently
used in composite arterial grafts because this technique
overcomes the pitfalls of aortic anastomosis, avoiding un-
necessary ascending aorta manipulation.
Our study was designed as a prospective randomized
comparison to avoid selection bias and to allow comparison
of treatment strategies of equal patient subsets. The study
population was almost unselected, and 75% of the patients
entered into the study underwent CABG surgery in the same
study period with few exclusion criteria. Patients less than
50 years of age were excluded for ethical reason related to
the use of SVGs. High-risk patients (EuroSCORE of 7
and left ventricular ejection fraction of 25%) were not
included because the number of patients in our study was
insufficient to warrant a homogenous distribution of patients
at high risk.
Our study had 2 main objectives. The first objective was
to assess the safety of total arterial revascularization with
composite grafts in comparison with conventional revascu-
larization. This study showed that early morbidity and mor-
tality were nearly identical in the 2 groups. Patients under-
going full arterial revascularization did not show any
increase in postoperative complications, such as intraoper-
ative myocardial infarction, bleeding, sternal dehiscence,
blood transfusion, mechanical ventilatory support, and in-
tensive care unit stay. The operative time was absolutely
comparable between the groups, whereas CPB duration was
significantly shorter in group 1 because of the reduced
number of proximal aortic anastomoses. The mean number
of grafted vessels was similar between the groups, indicat-
ing that composite arterial grafts allowed a full revascular-
ization.
The second objective of our study was to demonstrate the
usefulness of full myocardial revascularization with com-
posite arterial grafts, even in the short term to midterm,
because the majority of previous studies demonstrated in-
cremental benefits of multiple arterial grafts only in the long
term.7,8,12,23 However, almost all those studies were retro-
spective and therefore at risk of bias for the selection of
treatment and equal patient subsets. Our randomized study
showed that total arterial revascularization with composite
arterial grafts clearly improved the midterm outcome in
terms of angina recurrence, PTCA reintervention, and free-
dom from cardiac-related events. Patients undergoing
Figure 3. Comparison of event-free survival (nonfatal myocardial infarction, angina recurrence, graft occlusion,
need of PTCA reintervention, and late death) in patients receiving total arterial revascularization (full arterial)
versus conventional CABG surgery (conventional).
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CABG surgery with SVGs (in addition to the LITA on the
LAD) had a 7.95 times higher risk of development of
recurrence of angina.
Angiography confirmed the clinical evidence, showing a
significantly lower graft patency rate in patients receiving
SVGs. The patency of SVGs was similar to that previously
reported. Moreover, the arterial conduit patency rate of 99%
suggests that the use of composite arterial grafts not only
expands the possibilities for full arterial revascularization
but might improve clinical and angiographic results.
Angiography in our study also demonstrated that the RA,
when used as a composite graft, might offer an excellent
midterm patency rate comparable with that of the RITA,
regardless of the location of the target vessel.
Among patients treated with RA grafts, there was no
clinical evidence or angiographic demonstration of early or
late arterial spasm, suggesting that preoperative, intraoper-
ative, and postoperative Ca-channel blocker treatment
was effective to control RA vasoreactivity.
We believe that the use of composite arterial conduits
might play an important role in the reduction of pitfalls
associated with the use of in situ ITAs. This study evidenced
several benefits of total arterial revascularization that were
not evident in many other reports. In particular, those ben-
efits were evident in the short term to midterm, whereas
almost all comparison of arterial versus conventional grafts
was able to demonstrate differences only in the long term
(up to 10-15 years). This fact might be related to the
extremely high prevalence of diabetes in our population
(40.5%). Diabetes has been identified as an independent
predictor and incremental risk factor for cardiac-related
events and both overall and late cardiac death.7,8,24 When
we analyzed the effect of diabetes on cardiac-related mor-
bidity, we found tremendous differences in terms of actu-
arial survival free from any cardiac events when the diabetic
patients where compared with the remaining population
(Figure 4).
In addition, our results showed that diabetes negatively
affected the outcome only of the patients treated with SVGs.
In other words, patients with total arterial revascularization
had the same outcome, regardless of the presence of diabe-
tes. The follow-up of these patients will be continued at 5
and 10 years to confirm, in the long term, the superior
benefits of total arterial revascularization when compared
with those of conventional surgery.
The characteristics of patients undergoing CABG sur-
gery have been steadily worsening during the last 10 years.
Today, patients undergoing CABG are not only older, with
a higher number of preoperative risk factors, but they have
undergone multiple PTCA procedures before surgical inter-
vention. Coronary artery characteristics also worsened, and
today, the higher degree of atheromatous degeneration re-
sults in an important reduction of both coronary artery
diameter and run-off. In these circumstances the use of
Figure 4. Comparison of event-free survival (nonfatal myocardial infarction, angina recurrence, graft occlusion,
need of PTCA reintervention, and late death) in diabetic versus nondiabetic patients.
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SVGs might be associated with a significantly higher risk of
graft occlusion, even in the short term to midterm. This
means that the effect of full arterial revascularization on the
outcome of patients undergoing CABG might be more
evident than previously reported.
In conclusion, this study provides additional evidence
that the use of composite arterial grafts is safe and useful to
achieve full arterial revascularization. The study clearly
indicates that total myocardial revascularization provides
superior clinical results when compared with conventional
CABG, even in the short term to midterm. Arterial conduit–
related benefits were evident and significant in terms of a
reduced recurrence of angina and graft patency rate and a
lower incidence of late cardiac events.
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Discussion
Dr Thoralf M. Sundt (Rochester, Minn). The study just pre-
sented joins a growing body of literature documenting the safety of
complete arterial revascularization using a composite conduit tech-
nique. Dr Muneretto and his colleagues should be proud of this
contribution. Their results are outstanding. The authors have gone
a step beyond previous studies in two important ways. First, they
have examined the impact of complete arterial revascularization,
not just the impact of a second arterial graft, on outcomes. Second,
they have done so in the context of a prospectivly randomized
study. The authors should be proud of the design of their study.
However, it is important to remember, just as Professor Turina
noted earlier, that a randomized study design does not guarantee
freedom from selection bias. It just shifts the potential bias to the
point of entry into the trial. In the study, patients undergoing
emergency operation, those with an ejection fraction less than 25%
and those with a EuroSCORE profile higher than 7 were excluded.
This leads to my first question. Is this study group representative
of your general practice? During the study interval, what percent-
age of patients were entered into the study?
Dr Muneretto. Thank you, Dr Sundt, for your kind remarks.
We designed our study in an attempt to answer three main ques-
tions. First, whether the use of a composite arterial graft is a safe
technique in coronary surgery. Then we evaluated whether this
technique is useful to achieve a full arterial revascularization in all
patients. Finally, we studied the impact of full arterial revascular-
ization on outcome at short and midterm. Our randomized evalu-
ation was designed to answer those questions avoiding selection
bias.
Of course I fully agree with you about the fact that a random-
ized study may not completely eliminate selection bias that could
be shifted to the entry point of the trial. This did not happen in our
study in which the study population was relatively unselected. As
you noted, some patients were excluded: patients less than 50 years
of age because of ethical reasons (related to the use of the SVGs)
and high risk patients (left ventricular ejection fraction less than
25, EuroSCORE higher than 7) because the number of those
patients was very small and insufficient to guarantee an equal
distribution between the groups. An unbalanced high-risk patient
distribution could have affected reliability of the study. However,
ut except for these few exclusions, more than 85% of patients
undergoing coronary surgery in the same study period were en-
rolled in the trial.
Dr Sundt. Thank you. My second question relates to the
management of coronary arteries with only moderate stenoses.
What is your threshold stenosis for grafting—50%, 70%? Would
you graft a target vessel with a 50% stenosis with an artery, a vein,
or leave it ungrafted? In addition, you stated in your manuscript
that of the three grafting strategies, the ITA radial artery T graft
was your preferred approach when the stenosis of the obtuse
marginal was “less severe.” In our experience in St Louis, Rick
Barner and I found that it was in just this particular circumstance
that there was risk of occlusion of the proximal limb of the T
graft—the segment between the ITA and the first anastomosis. Did
you see such occlusions or string signs?
Dr Muneretto. It is a hard task trying to identify a cutoff value
of threshold stenoses for grafting. In fact, the same degree of
stenosis may cause quite different coronary flow impairment de-
pending on type, diameter, and location of the coronary vessel, left
ventricular mass, stress indices, and many other factors. In addi-
tion, some proximal stenoses may be life-threatening, and the
problem becomes even more complex in patients with unstable
angina in which the degree of the stenosis is a dynamic process. I
can only answer that we are more aggressive in patients with
unstable angina and in those with a proximal lesion of the RCA
greater than 50%. Usually we graft these patients. Conversely, we
try to respect stenosis of the circumflex and marginal branches less
than 70%, especially if those vessels are likely to be treated by
angioplasty. Our approach for less than severe stenosis of marginal
branches is basically a Y graft based on multiple side-to-side
anastomoses. I am aware of your outstanding experience in the use
of composite grafts: you reported in The Annals of Thoracic
Surgery in 1999 and 2001 that RA patency was sensitive to both
location and target stenosis. We share your opinion and we took
advantages of your observations in our experience. We do believe
that in case of borderline stenosis of marginal branches the RITA
in Y graft should be preferred (instead of the RA) because this
graft seems to be less sensitive to competitive flow: it may become
a threadlike artery, but this functional and reversible change allows
the graft to maintain its patency.
Dr Sundt. Finally, you have failed to show any impact of
complete arterial revascularization on survival. This is not a sur-
prise as the follow-up is short and the numbers are small. In my
view, given the remarkable effectiveness of current medical, in-
terventional cardiologic, and surgical treatment of ischemic heart
disease, one needs the kinds of numbers only achievable at The
Cleveland Clinic and the kinds of statistics only comprehensible to
Dr Blackstone to demonstrate such a difference. This is also the
case with angioplasty versus surgery trials: it is difficult, if not
impossible, to demonstrate a difference in survival. On the other
hand, you have shown a remarkable difference in recurrent angina
in a very short time interval. This is an exciting finding as we try
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to improve the results of surgical revascularization. A reduction in
recurrent angina is exactly what we should hope to achieve with
complete arterial revascularization. It is an important clinical end
point. Should we then expand our indications for complete arterial
revascularization? Most of us have considered applying arterial
grafts only to young patients at risk for late graft occlusion,
looking at the long run. However, if this marked early benefit is
valid, the argument really applies to everyone. Should everyone
get arteries?
Dr Muneretto. I would say yes. I do believe that the indica-
tions for full arterial revascularization should be expanded even in
older patients. A randomized clinical trial comparing results of full
arterial revascularization versus conventional surgery in patients
older than 75 years of age is underway at our institution, and we
strongly endorse proceeding with a multicenter trial in collabora-
tion with experienced centers to confirm our data in a larger cohort
of patients.
Dr Robert A. Dion (Leiden, The Netherlands). I am a warm
supporter of arterial grafting anyway. My question is more a
technical one. Why are you only pleading for the Y graft? What is
the place in your practice for a bilateral pedicled graft? In the
majority of the patient population that we see, we still can use the
RITA and LITA without making them free. If you have decided to
just restrict your use of ITAs to the Y construction, do you perform
systematically a preoperative angiography of the LITA?
Dr Muneretto. Thank you, Dr Dion, for your interesting ques-
tion that allow me to discuss an important aspect of this technique.
At the beginning of our experience in full arterial revasculariza-
tion, we used in situ bilateral ITA grafts with the addition of the
RA as a free graft if required. We introduced the use of composite
arterial grafts to overcome some anatomic limitations of in situ
ITAs. However, the use of composite grafts has been steadily
expanded because this technique not only overcomes anatomic
limitations of in situ grafts but also reduces technical pitfalls; it is
more reproducible and easier to teach to young surgeons. In other
words, composite arterial graft technique is easy and requires less
experience than the in situ graft technique.
Dr Dion. Did you perform a preoperative angiography of the
LITA?
Dr Muneretto. No, we did not. We routinely carried out an
echo Doppler evaluation of the supra-aortic vessels, and angiog-
raphy was restricted to a few patients with stenosis.
Dr Richard F. Brodman (New York, NY). You make a very
good point that we all are aware of: when we do coronary bypass
surgery, some of the grafts are for survival and others are quality
of life. You have demonstrated very nicely that multiple arterial
grafts improve the quality of life early after CABG.. With regard
to your early patency data, you show a decrease in patency in the
vein graft group compared with the arterial bypass group. Is that
due to a selection bias since you had very little angina in the
all-arterial bypass group and symptoms in the vein graft group?
Your findings differ from other studies in which early vein graft
patency is the same as arterial graft patency.
Dr Muneretto. Thank you very much for your question, Dr
Brodman. We presented a prevalence of diabetes in our population
that was considerably higher when compared with other previous
studies, and we believe that this fact may affect early patency of
SVGs. In addition, patients referred to our institution, even if
diabetic, are usually treated with repeated angioplasty in first
instances. As a consequence, many of those patients may have a
poor coronary anatomy and runoff at the time of operation. This
fact may have been a bias influencing the results. However, the
overall patency of SVGs in our study (89% overall, with 91%
patency on obtuse marginal district and a little bit less for the distal
RCA) does not differ from previous reports in the literature, and
the significant differences in terms of patency between the groups
were mainly related to the excellent patency of the arterial grafts.
Dr Brodman. I just have one follow-up comment. I have been
using RAs routinely in my practice since 1993, and I have always
believed that you should do the best operation on a patient irre-
spective of age. I have not used age as a contraindication to the use
of an RA graft. My oldest patient was 95 when I performed her
operation.
Dr Antonio M. Calafiore (Chieti, Italy). Looking at your data,
you report a high number of patients with diabetes. Do you think
that this incidence affected the results in terms of patency rate and
event-free survival. In other words, if you evaluate your data
without this group of patients, will you have the same results?
Dr Muneretto. Thank you very much, Dr Calafiore. Yes, we
did. As already pointed out, diabetes was highly prevalent in our
study population and had a tremendous deleterious impact on the
outcome of patients, particularly on those treated with SVGs.
However, even when diabetic patients were excluded from the
analysis, patients receiving arterial grafts showed a better outcome
than those receiving SVGs. In other words, the presence of dia-
betes worsened the results and negatively affected the outcome,
especially in patients receiving SVGs, thus making the difference
between the groups more striking.
Dr Craig R. Smith (New York, NY). I have a quick technical
question. I was surprised, maybe even shocked, to hear that you
prefer to use the RA to construct the conduits before exhausting all
the possibilities of the ITAs. Can you explain your bias in favor of
that?
Dr Muneretto. Thank you, Dr Smith. First, multiple side-to-
side anastomoses with the RA are quite easy when compared with
multiple side-to-side anastomoses with the RITA, at least in our
experience. The second concern is related to the duration of the
operation. The simultaneous harvesting of the RA and ITA reduces
the duration of the surgical procedure with clinical and economical
benefits. In addition, it could be safely used in all patients regard-
less of the presence of diabetes, chronic obstructive pulmonary
disease, and other risk factors. Our experience seems to confirm
that early patency of RA grafts is absolutely similar to that of the
ITAs.
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